Nova Minerals Stock Price, News & Analysis

Nova (NASDAQ: NVA) reported 2025 diamond‑core results from the RPM North deposit at the Estelle project (Jan 7, 2026), confirming broad near‑surface gold mineralization and a new eastern strike extension that is open along strike.

Key intercepts include RPM-080: 180m @ 0.7 g/t Au from 4m (incl. 108m @ 1.1 g/t; 2m @ 19.7 g/t), RPM-078: 162m @ 1.0 g/t Au from 3m (incl. 54m @ 1.6 g/t), RPM-068: 167m @ 0.7 g/t Au from 187m, and RPM-070: 165m @ 0.6 g/t Au from 3m. Results are planned to be incorporated into an updated Mineral Resource Estimate to support the Feasibility Study, while metallurgical, mining and optimization studies continue.

Nova Minerals (NASDAQ: NVA) addressed media speculation about a possible purchase of Pakistani antimony concentrate after a Financial Times article on 29 December 2025 quoted comments attributed to CEO Christopher Gerteisen.

The company says discussions about sourcing antimony concentrate are exploratory and intended for testing plant capability; no binding terms have been agreed. Nova reiterated it will disclose any binding, material arrangement per exchange rules if and when it occurs. Nova's 2026 priorities are completing the Feasibility Study for its gold assets and commencing production of military-grade antimony trisulfide, supported by a US$43.4 million award from the U.S. Department of Defense.

Nova Minerals (Nasdaq: NVA) closed an underwritten public offering of 2,928,300 ADS (1 ADS = 12 ordinary shares) at $6.83 per ADS, generating gross proceeds of approximately $20,000,000 before fees on Dec 22, 2025. The underwriters have a 45-day option to buy up to 439,245 additional ADS for overallotments. Proceeds are intended to fund exploration and development at the Estelle Gold and Critical Minerals Project in Alaska, including drilling, feasibility and environmental studies, camp expansion, permits, initial development activities, and working capital. ThinkEquity acted as sole book-running manager; the offering was made under a Form F-3 shelf registration declared effective Dec 17, 2025.

Nova Minerals (Nasdaq: NVA) priced an underwritten public offering of 2,928,300 ADS at $6.83 per ADS, representing gross proceeds of approximately $20,000,000, before underwriting discounts and offering expenses.

The ADS-to-ordinary-share ratio is 1:12 and the underwriters have a 45-day option for 439,245 ADS to cover over-allotments. The offering is expected to close on December 22, 2025, subject to customary closing conditions.

Proceeds are intended to fund exploration and development at the Estelle Project, including drilling, feasibility and environmental studies, camp expansion, permits, initial development activities, and general corporate purposes.

Nova Minerals (NASDAQ: NVA) announced that CEO Christopher Gerteisen will present live at two investor webinars on 10–11 December 2025 to review the company’s Estelle Gold and Critical Minerals Project in Alaska.

The presentation will cover the project’s multi‑million‑ounce resource, Nova’s strategy to advance its antimony assets and the recent US$43.4 million award from the Department of War. Live Q&A will follow each presentation and archived webcasts will be posted on the company website.

Nova Minerals (NASDAQ: NVA) has begun procurement of critical mining and processing equipment for its Estelle starter antimony operations and a downstream refinery at Port Mackenzie, Alaska, targeting first military-grade antimony trisulfide production in 2026/27. The company reports access to approximately A$83.0M in funding including A$17.5M cash and a US$43.4M (A$65.5M) 24-month award from the U.S. Department of War to support production.

FEED and logistics studies are nearing completion. Key purchases include mining fleet, crusher/screen, two ore sorters, mill, flotation and gravity circuits, with equipment delivery planned ahead of transport via a snow road in January 2026. Ore-sorting testwork showed 60.3% Sb recovery in a 500 kg Styx sample, upgrading feed from 15.2% to 35.2% Sb.

Nova Minerals (NASDAQ: NVA) released its Quarterly Activities and Cashflow Report for the quarter ended 30 Sep 2025, highlighting a US$43.4M (A$65.5M) 24‑month Defense Production Act award to ARR to accelerate a domestic antimony supply chain in Alaska and support drilling, studies and CAPEX.

The company reports access to >A$86.3M in funding (A$17.5M cash, A$65.5M DoW award, ~A$3.3M liquid investments/warrants), ongoing 2025 drilling and surface programs at Estelle with assays pending, and positive ore‑sorting and heap‑leach test results for RPM and Styx.

Nova Minerals (NASDAQ: NVA) announced that CEO Christopher Gerteisen will present at the Emerging Growth Conference webinar on October 23, 2025 (1:45pm US EST / 4:45am Australian EDT Oct 24). The presentation will cover updates on the Estelle Gold and Critical Minerals Project in Alaska and the company’s strategy to advance its antimony assets following a US$43.4 million award referenced for Department of War support. The live webinar will include a Q&A and an archived webcast and presentation will be available on the company website, EmergingGrowth.com, and the Emerging Growth YouTube channel. Registration link and presentation PDF are provided for investors.

Nova Minerals (NASDAQ: NVA) announced a 5-for-1 forward ADS split that changes the ADS ratio from 1 ADS:60 ordinary shares to 1 ADS:12 ordinary shares, effective on October 28, 2025, with first day of trading under the new ratio expected on October 29, 2025. ADR holders of record on October 27, 2025 will receive 4 additional ADSs for each ADS held; existing ADSs remain valid.

The warrant exercise price will be adjusted from $7.266 to $1.4532 per ADS and each public warrant will be adjusted from issuing 1 ADS to issuing 5 ADSs on exercise, leaving aggregate warrant economics unchanged. Deposit bank: The Bank of New York Mellon.